| Application no. and date | 18724753.1 (espacenet) (Federated) (European Patent Register), 20180430 | | Patent/reg. no. and date | DK/EP 3619208, 20230607 | | Publication date | 20200311 | | Priority no. and date | US 201762492571 P, 20170501 | | EP pub. no. and date |
EP 3619208 20200311 | | Effective date | | | Applicant/owner | Theravance Biopharma R&D IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | | | Inventor | THALLADI, Venkat R., 888 Foster City Boulevard
Apt. E3
Foster City, California 94404, US,
NZEREM, Jerry, 29 Woods Circle
South San Francisco, California 94080, US,
DABROS, Marta, 888 Foster City Boulevard Apt. Q2
Foster City, California 94404, US,
KLEINSCHEK, Melanie A., 30 Elizabeth Street
San Francisco, California 94110, US,
CRATER, Glenn D., 7108 Rippling Stone Lane
Raleigh, North Carolina 27612, US | | Representative | | | Opponent | | | IPC Class | A61K 31/4523 (2006.01) , A61P 11/00 (2006.01) , A61P 27/00 (2006.01) , C07D 471/04 (2006.01) | | Title | CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND | | Int. application no. | US2018030144 | | Int. publication no. | WO2018204236 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
